| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099304 | Journal of Crohn's and Colitis | 2014 | 7 Pages |
Abstract
Infliximab is an effective and safe rescue therapy for severe corticosteroid-refractory ulcerative colitis. A three-dose induction regimen seems to be the treatment of choice for preventing early colectomy. Severe endoscopic lesions appear to be predictor of short- and long-term colectomy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Rita Monterubbianesi, Annalisa Aratari, Alessandro Armuzzi, Marco Daperno, Livia Biancone, Maria Cappello, Vito Annese, Gabriele Riegler, Ambrogio Orlando, Angelo Viscido, Gianmichele Meucci, Antonio Gasbarrini, Luisa Guidi, Alessandro Lavagna,